Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.

Yves ReznikMartin CarvalhoSalha FendriGaetan PrevostLucy ChaillousJean Pierre RivelineHélène HanaireSéverine DuboisPatrick HouétoHélène PascheBeata Mianowska Pr Eric Renard

Published in: Diabetes, obesity & metabolism (2023)

AID combined with tailored HHC services significantly improved glycaemic control with no safety issues in people with type 2 diabetes previously under an MDI regimen with HHC. AID should be considered a safe option in these people when lacking acceptable glucose control.

Keyphrases

healthcare
randomized controlled trial
type diabetes
study protocol
primary care
transcription factor
mental health
blood glucose
systematic review
clinical trial
skeletal muscle
smoking cessation
metabolic syndrome
insulin resistance
social media